News Innovent gets OK for China's first home-grown IL-23p19 drug Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.
News As drug costs for US employers rise, some cut GLP-1s from pl... Pharmacy now represents 25% of employer healthcare spending, and employers are turning to DTC models and nontraditional PBMs to cut costs.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.